Radiopharmaceutical therapy (RPT) combined with external beam radiotherapy (EBRT) is emerging as a powerful approach in prostate cancer treatment. Historically rooted in early 89Sr trials, this ...
For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before the cancer comes back. Researchers at UCLA have found that a blend of a ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
Nubeqa plus androgen deprivation therapy displayed positive radiological progression-free survival results in early trial data. Among patients with metastatic hormone-sensitive prostate cancer, the ...
In 2013, a prostate-specific antigen (PSA) blood test revealed that Richard LaFrate's levels had jumped. Previously in a normal range, LaFrate's PSA was now above 6 ng/mL, indicating an elevated ...
Prostate cancer is the second leading cause of cancer-related deaths among American men, claiming almost 35,000 lives annually. Androgens, male sex hormones, fuel the growth of most prostate tumors by ...
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
“Me encontraron càncer en la pròstata,” my father told me. “They found cancer in my prostate.” As a cancer researcher who knows very well about the high incidence and decreased survival rates of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback